ESR statement on the stepwise development of imaging biomarkers
Author:
- European Society Of Radiology (Esr)E(European Society Of Radiology (Esr)
Open Access
- 9 February 2013
- journal article
- statement
- Published by Springer Nature in Insights into Imaging
- Vol. 4 (2) , 147-152
Abstract
Development of imaging biomarkers is a structured process in which new biomarkers are discovered, verified, validated and qualified against biological processes and clinical end-points. The validation process not only concerns the determination of the sensitivity and specificity but also the measurement of reproducibility. Reproducibility assessments and standardisation of the acquisition and data analysis methods are crucial when imaging biomarkers are used in multicentre trials for assessing response to treatment. Quality control in multicentre trials can be performed with the use of imaging phantoms. The cost-effectiveness of imaging biomarkers also needs to be determined. A lot of imaging biomarkers are being developed, but there are still unmet needs—for example, in the detection of tumour invasiveness. Main Messages • Using imaging biomarkers to streamline drug discovery and disease progression is a huge advancement in healthcare. • The qualification and technical validation of imaging biomarkers pose unique challenges in that the accuracy, methods, standardisations and reproducibility are strictly monitored. • The clinical value of new biomarkers is of the highest priority in terms of patient management, assessing risk factors and disease prognosis.Keywords
This publication has 47 references indexed in Scilit:
- Preclinical multimodality phantom design for quality assurance of tumor size measurementBMC Medical Physics, 2011
- Diffusion coefficient measurement using a temperature‐controlled fluid for quality control in multicenter studiesJournal of Magnetic Resonance Imaging, 2011
- Dependence of temporal diffusion spectra on microstructural properties of biological tissuesMagnetic Resonance Imaging, 2011
- Automated registration of sequential breath-hold dynamic contrast-enhanced MR images: a comparison of three techniquesMagnetic Resonance Imaging, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)Journal of Hepatology, 2010
- White paper on imaging biomarkersInsights into Imaging, 2010
- Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease PredictionJAMA, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Magnetic Resonance Elastography for the Noninvasive Staging of Liver FibrosisGastroenterology, 2008